is semaglutide a sglt2 inhibitor vs GLP-1 for CKD: Which Better? SGLT2 Inhibitor-induced Euglycemic Diabetic Ketoacidosis

Pediatr Res 47:1723

The investigation reported here differs from previous studies by combining several important aspects: (i) the large size of the cohort selected, with 105 participants, including 60 participants with ME/CFS (45 women and 15 men) as well as controls screened for sedentary behavior

Aayushi: All in all, a lot of money is going into researching what could lead to more weight loss than the existing range of drugs

4) Underexplored therapeutic strategies and model limitations: Preclinical studies have relied heavily on lupus-prone mouse models (e.g., MRL/lpr mice), which may not fully recapitulate human LNs complexity (e.g., genetic heterogeneity, variable disease progression, and response to therapy)

Scrocchi LA, Brown TJ, Maclusky N, et al